

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle contraction (GO:0003009) | 8.92242423 |
| 2 | actin-mediated cell contraction (GO:0070252) | 8.85655655 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.63727069 |
| 4 | sarcomere organization (GO:0045214) | 7.80847302 |
| 5 | skeletal muscle adaptation (GO:0043501) | 7.63846801 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.11580772 |
| 7 | plasma membrane repair (GO:0001778) | 7.00393946 |
| 8 | myofibril assembly (GO:0030239) | 6.99370398 |
| 9 | actin filament-based movement (GO:0030048) | 6.61068604 |
| 10 | striated muscle contraction (GO:0006941) | 6.57798269 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.31959448 |
| 12 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.11167336 |
| 13 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.94242568 |
| 14 | skeletal muscle fiber development (GO:0048741) | 5.69295065 |
| 15 | regulation of cell communication by electrical coupling (GO:0010649) | 5.60550493 |
| 16 | cardiac myofibril assembly (GO:0055003) | 5.46788725 |
| 17 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.38512802 |
| 18 | actomyosin structure organization (GO:0031032) | 5.26964338 |
| 19 | purine nucleotide salvage (GO:0032261) | 5.26439522 |
| 20 | cardiac muscle contraction (GO:0060048) | 5.24470639 |
| 21 | response to inactivity (GO:0014854) | 5.24135804 |
| 22 | creatine metabolic process (GO:0006600) | 5.09221902 |
| 23 | skeletal muscle tissue regeneration (GO:0043403) | 5.07488588 |
| 24 | heart process (GO:0003015) | 5.04329815 |
| 25 | heart contraction (GO:0060047) | 5.04329815 |
| 26 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.03054981 |
| 27 | NADH metabolic process (GO:0006734) | 5.01293635 |
| 28 | muscle contraction (GO:0006936) | 4.92175898 |
| 29 | glycogen catabolic process (GO:0005980) | 4.89269906 |
| 30 | striated muscle atrophy (GO:0014891) | 4.87492912 |
| 31 | myotube cell development (GO:0014904) | 4.86334297 |
| 32 | regulation of relaxation of muscle (GO:1901077) | 4.77135178 |
| 33 | striated muscle adaptation (GO:0014888) | 4.70428773 |
| 34 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.69590807 |
| 35 | tricarboxylic acid cycle (GO:0006099) | 4.67827064 |
| 36 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.65587360 |
| 37 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.64421836 |
| 38 | carnitine shuttle (GO:0006853) | 4.63993283 |
| 39 | response to muscle activity (GO:0014850) | 4.57267961 |
| 40 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.55930358 |
| 41 | IMP metabolic process (GO:0046040) | 4.54727157 |
| 42 | glucan catabolic process (GO:0009251) | 4.52245037 |
| 43 | muscle atrophy (GO:0014889) | 4.47645726 |
| 44 | muscle system process (GO:0003012) | 4.47545957 |
| 45 | gluconeogenesis (GO:0006094) | 4.44535268 |
| 46 | 2-oxoglutarate metabolic process (GO:0006103) | 4.31379898 |
| 47 | muscle fiber development (GO:0048747) | 4.23786461 |
| 48 | cellular polysaccharide catabolic process (GO:0044247) | 4.19774263 |
| 49 | regulation of coenzyme metabolic process (GO:0051196) | 4.16774229 |
| 50 | regulation of cofactor metabolic process (GO:0051193) | 4.16774229 |
| 51 | cardiac muscle cell development (GO:0055013) | 4.13824042 |
| 52 | IMP biosynthetic process (GO:0006188) | 4.13493768 |
| 53 | glycogen biosynthetic process (GO:0005978) | 4.11568087 |
| 54 | glucan biosynthetic process (GO:0009250) | 4.11568087 |
| 55 | regulation of actin filament-based movement (GO:1903115) | 4.07589716 |
| 56 | hexose biosynthetic process (GO:0019319) | 4.03273442 |
| 57 | cytidine deamination (GO:0009972) | 3.97024161 |
| 58 | cytidine metabolic process (GO:0046087) | 3.97024161 |
| 59 | cytidine catabolic process (GO:0006216) | 3.97024161 |
| 60 | fructose metabolic process (GO:0006000) | 3.94372573 |
| 61 | negative regulation of muscle hypertrophy (GO:0014741) | 3.94317365 |
| 62 | muscle adaptation (GO:0043500) | 3.93319840 |
| 63 | polysaccharide catabolic process (GO:0000272) | 3.92378840 |
| 64 | neuronal action potential propagation (GO:0019227) | 3.91540484 |
| 65 | regulation of striated muscle contraction (GO:0006942) | 3.90841137 |
| 66 | cardiac cell development (GO:0055006) | 3.85545250 |
| 67 | muscle cell cellular homeostasis (GO:0046716) | 3.83542432 |
| 68 | regulation of membrane repolarization (GO:0060306) | 3.78733873 |
| 69 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.77004185 |
| 70 | striated muscle cell development (GO:0055002) | 3.71878932 |
| 71 | striated muscle hypertrophy (GO:0014897) | 3.67119646 |
| 72 | fatty acid transmembrane transport (GO:1902001) | 3.64925261 |
| 73 | oxidative phosphorylation (GO:0006119) | 3.62430112 |
| 74 | cardiac muscle hypertrophy (GO:0003300) | 3.60799555 |
| 75 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.57132561 |
| 76 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.57132561 |
| 77 | monosaccharide biosynthetic process (GO:0046364) | 3.56432544 |
| 78 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.56305590 |
| 79 | regulation of sarcomere organization (GO:0060297) | 3.55144317 |
| 80 | oxaloacetate metabolic process (GO:0006107) | 3.52598337 |
| 81 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.47379659 |
| 82 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.45111662 |
| 83 | glycogen metabolic process (GO:0005977) | 3.45080439 |
| 84 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.44654643 |
| 85 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.42295199 |
| 86 | adult heart development (GO:0007512) | 3.40502251 |
| 87 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.39709983 |
| 88 | muscle tissue morphogenesis (GO:0060415) | 3.39483818 |
| 89 | glucan metabolic process (GO:0044042) | 3.36415558 |
| 90 | cellular glucan metabolic process (GO:0006073) | 3.36415558 |
| 91 | muscle organ development (GO:0007517) | 3.36132800 |
| 92 | quinone biosynthetic process (GO:1901663) | 3.34613419 |
| 93 | ubiquinone biosynthetic process (GO:0006744) | 3.34613419 |
| 94 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.33507834 |
| 95 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.32602682 |
| 96 | regulation of sulfur metabolic process (GO:0042762) | 3.30706078 |
| 97 | positive regulation of myoblast differentiation (GO:0045663) | 3.29667816 |
| 98 | muscle structure development (GO:0061061) | 3.27988970 |
| 99 | muscle hypertrophy (GO:0014896) | 3.27457109 |
| 100 | positive regulation of myotube differentiation (GO:0010831) | 3.25703007 |
| 101 | muscle cell fate commitment (GO:0042693) | 3.25050719 |
| 102 | carnitine transmembrane transport (GO:1902603) | 3.23284329 |
| 103 | neuromuscular synaptic transmission (GO:0007274) | 3.21251884 |
| 104 | positive regulation of synapse maturation (GO:0090129) | 3.19542813 |
| 105 | myoblast fusion (GO:0007520) | 3.16538363 |
| 106 | glycolytic process (GO:0006096) | 3.13399085 |
| 107 | regulation of muscle contraction (GO:0006937) | 3.13081076 |
| 108 | muscle organ morphogenesis (GO:0048644) | 3.12737987 |
| 109 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.11573671 |
| 110 | muscle hypertrophy in response to stress (GO:0003299) | 3.11573671 |
| 111 | cardiac muscle adaptation (GO:0014887) | 3.11573671 |
| 112 | muscle cell development (GO:0055001) | 3.09871957 |
| 113 | skeletal muscle tissue development (GO:0007519) | 3.07954661 |
| 114 | response to activity (GO:0014823) | 2.99372569 |
| 115 | myotube differentiation (GO:0014902) | 2.99230287 |
| 116 | aspartate family amino acid catabolic process (GO:0009068) | 2.99109080 |
| 117 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.95302708 |
| 118 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.94734116 |
| 119 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.94734116 |
| 120 | regulation of the force of heart contraction (GO:0002026) | 2.87210178 |
| 121 | respiratory system process (GO:0003016) | 2.80326876 |
| 122 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.70034275 |
| 123 | otic vesicle formation (GO:0030916) | 2.65208066 |
| 124 | muscle filament sliding (GO:0030049) | 10.7915587 |
| 125 | actin-myosin filament sliding (GO:0033275) | 10.7915587 |
| 126 | regulation of skeletal muscle contraction (GO:0014819) | 10.0296829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.90648899 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.04990319 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.99863660 |
| 4 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.39640552 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.31848952 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.13817870 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.10659054 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.06085655 |
| 9 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.82910574 |
| 10 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.82910574 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.56190137 |
| 12 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.51998866 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37344370 |
| 14 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.35305501 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15695006 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03128564 |
| 17 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.02267194 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.95885297 |
| 19 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.94846333 |
| 20 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.94136257 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.87355903 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80086489 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.78616489 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75877560 |
| 25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.69419335 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.67805156 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.66910626 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65970039 |
| 29 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61024903 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.61023817 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60032845 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58989489 |
| 33 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58146169 |
| 34 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.56689653 |
| 35 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55499043 |
| 36 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.54939209 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.51787789 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51521039 |
| 39 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46115315 |
| 40 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.45148283 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43452375 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.41656319 |
| 43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.40501091 |
| 44 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.40317142 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40195452 |
| 46 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40022916 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39175501 |
| 48 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.38749766 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36628057 |
| 50 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.36440734 |
| 51 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.35486121 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34876278 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33535389 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32395650 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29744702 |
| 56 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.29604983 |
| 57 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.29599937 |
| 58 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.28239089 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.26513211 |
| 60 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24653336 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24245439 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22901546 |
| 63 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.22859808 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.22233897 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.22140679 |
| 66 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20966107 |
| 67 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.19489320 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19281815 |
| 69 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.18634864 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18462382 |
| 71 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.18078365 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.17049385 |
| 73 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16579542 |
| 74 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16347649 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16053039 |
| 76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15803426 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15165829 |
| 78 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.15100890 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.15100890 |
| 80 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.14421536 |
| 81 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12949527 |
| 82 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.12749945 |
| 83 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12579532 |
| 84 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.07881478 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06809717 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05997718 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05373272 |
| 88 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04005500 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03959619 |
| 90 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02526198 |
| 91 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02163655 |
| 92 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.01163927 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00555078 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00415787 |
| 95 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00174222 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99619084 |
| 97 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99147808 |
| 98 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98825733 |
| 99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98194875 |
| 100 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.98112507 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97782778 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97331578 |
| 103 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.97317941 |
| 104 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96765753 |
| 105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96450717 |
| 106 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.95976038 |
| 107 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.95974896 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95536397 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94853404 |
| 110 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94506209 |
| 111 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94432004 |
| 112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94154891 |
| 113 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94134523 |
| 114 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.93967934 |
| 115 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93927703 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92584416 |
| 117 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92434018 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92079016 |
| 119 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92036566 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91726673 |
| 121 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.91576187 |
| 122 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91473713 |
| 123 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.91391950 |
| 124 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.90744822 |
| 125 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89969955 |
| 126 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89568735 |
| 127 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89178806 |
| 128 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88839245 |
| 129 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88685715 |
| 130 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88198856 |
| 131 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88112622 |
| 132 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.87927497 |
| 133 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85391086 |
| 134 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83409196 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83359458 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82974796 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82097572 |
| 138 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81865544 |
| 139 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81755039 |
| 140 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.81353362 |
| 141 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.80879979 |
| 142 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80435891 |
| 143 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80348664 |
| 144 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.80117649 |
| 145 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79219782 |
| 146 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78672972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.70831903 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 6.50588454 |
| 3 | MP0000749_muscle_degeneration | 6.06561601 |
| 4 | MP0000751_myopathy | 5.85196054 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 4.65086215 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.12770780 |
| 7 | MP0002106_abnormal_muscle_physiology | 3.83856611 |
| 8 | MP0000747_muscle_weakness | 3.53600772 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.38904887 |
| 10 | MP0000759_abnormal_skeletal_muscle | 3.35656705 |
| 11 | MP0002269_muscular_atrophy | 3.31232525 |
| 12 | MP0005369_muscle_phenotype | 3.16666095 |
| 13 | MP0004084_abnormal_cardiac_muscle | 3.13228074 |
| 14 | MP0005620_abnormal_muscle_contractility | 3.12606487 |
| 15 | MP0000750_abnormal_muscle_regeneration | 3.01896273 |
| 16 | MP0004130_abnormal_muscle_cell | 2.97275588 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.83293377 |
| 18 | MP0005330_cardiomyopathy | 2.58108590 |
| 19 | MP0004233_abnormal_muscle_weight | 2.38789193 |
| 20 | MP0002972_abnormal_cardiac_muscle | 2.09111342 |
| 21 | MP0004147_increased_porphyrin_level | 1.88710488 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.77676095 |
| 23 | MP0004484_altered_response_of | 1.75660975 |
| 24 | MP0003137_abnormal_impulse_conducting | 1.74584088 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.65072198 |
| 26 | MP0000733_abnormal_muscle_development | 1.64637370 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.63691413 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.63277396 |
| 29 | MP0005385_cardiovascular_system_phenoty | 1.54701890 |
| 30 | MP0001544_abnormal_cardiovascular_syste | 1.54701890 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.52804249 |
| 32 | MP0002108_abnormal_muscle_morphology | 1.49173133 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.39630787 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.18879017 |
| 35 | MP0003123_paternal_imprinting | 1.17013515 |
| 36 | MP0002234_abnormal_pharynx_morphology | 1.07102883 |
| 37 | MP0010030_abnormal_orbit_morphology | 1.06119726 |
| 38 | MP0003879_abnormal_hair_cell | 1.02655049 |
| 39 | MP0004270_analgesia | 1.01042946 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.00603843 |
| 41 | MP0004085_abnormal_heartbeat | 0.99796589 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 0.99361130 |
| 43 | MP0003122_maternal_imprinting | 0.96185335 |
| 44 | MP0004859_abnormal_synaptic_plasticity | 0.95683806 |
| 45 | MP0001661_extended_life_span | 0.93845373 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 0.93641353 |
| 47 | MP0001346_abnormal_lacrimal_gland | 0.91065251 |
| 48 | MP0003950_abnormal_plasma_membrane | 0.91023517 |
| 49 | MP0005266_abnormal_metabolism | 0.89887350 |
| 50 | MP0002734_abnormal_mechanical_nocicepti | 0.89428264 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 0.88256145 |
| 52 | MP0000343_altered_response_to | 0.86564305 |
| 53 | MP0004510_myositis | 0.82903212 |
| 54 | MP0002822_catalepsy | 0.81951240 |
| 55 | MP0000372_irregular_coat_pigmentation | 0.81548577 |
| 56 | MP0006138_congestive_heart_failure | 0.78019080 |
| 57 | MP0003828_pulmonary_edema | 0.76400735 |
| 58 | MP0000266_abnormal_heart_morphology | 0.75481272 |
| 59 | MP0005670_abnormal_white_adipose | 0.74458889 |
| 60 | MP0005375_adipose_tissue_phenotype | 0.71886075 |
| 61 | MP0002971_abnormal_brown_adipose | 0.70928446 |
| 62 | MP0002249_abnormal_larynx_morphology | 0.70089582 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 0.67398226 |
| 64 | MP0006276_abnormal_autonomic_nervous | 0.65827382 |
| 65 | MP0004134_abnormal_chest_morphology | 0.64075369 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 0.59182138 |
| 67 | MP0000013_abnormal_adipose_tissue | 0.58530143 |
| 68 | MP0008961_abnormal_basal_metabolism | 0.57525779 |
| 69 | MP0005646_abnormal_pituitary_gland | 0.57144647 |
| 70 | MP0006054_spinal_hemorrhage | 0.56479700 |
| 71 | MP0008569_lethality_at_weaning | 0.55715397 |
| 72 | MP0000534_abnormal_ureter_morphology | 0.55519709 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54999339 |
| 74 | MP0005334_abnormal_fat_pad | 0.53617247 |
| 75 | MP0005451_abnormal_body_composition | 0.52719230 |
| 76 | MP0004858_abnormal_nervous_system | 0.50883871 |
| 77 | MP0002114_abnormal_axial_skeleton | 0.49773803 |
| 78 | MP0000955_abnormal_spinal_cord | 0.49151161 |
| 79 | MP0002067_abnormal_sensory_capabilities | 0.48201679 |
| 80 | MP0002184_abnormal_innervation | 0.46516010 |
| 81 | MP0002272_abnormal_nervous_system | 0.46166431 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.45814414 |
| 83 | MP0009672_abnormal_birth_weight | 0.44883872 |
| 84 | MP0005503_abnormal_tendon_morphology | 0.44358654 |
| 85 | MP0003880_abnormal_central_pattern | 0.43907025 |
| 86 | MP0002064_seizures | 0.43728041 |
| 87 | MP0000566_synostosis | 0.43655608 |
| 88 | MP0001440_abnormal_grooming_behavior | 0.43473665 |
| 89 | MP0005332_abnormal_amino_acid | 0.43277704 |
| 90 | MP0009250_abnormal_appendicular_skeleto | 0.43093639 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.42016574 |
| 92 | MP0003948_abnormal_gas_homeostasis | 0.41517455 |
| 93 | MP0004197_abnormal_fetal_growth/weight/ | 0.41491308 |
| 94 | MP0000003_abnormal_adipose_tissue | 0.40136061 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.40121184 |
| 96 | MP0001486_abnormal_startle_reflex | 0.37934241 |
| 97 | MP0003385_abnormal_body_wall | 0.37928043 |
| 98 | MP0005452_abnormal_adipose_tissue | 0.37852341 |
| 99 | MP0002081_perinatal_lethality | 0.36974224 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.36527002 |
| 101 | MP0001299_abnormal_eye_distance/ | 0.34787214 |
| 102 | MP0002909_abnormal_adrenal_gland | 0.34681244 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.34000910 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.32216067 |
| 105 | MP0005386_behavior/neurological_phenoty | 0.30348543 |
| 106 | MP0004924_abnormal_behavior | 0.30348543 |
| 107 | MP0002128_abnormal_blood_circulation | 0.30182543 |
| 108 | MP0001853_heart_inflammation | 0.29385783 |
| 109 | MP0000678_abnormal_parathyroid_gland | 0.29115295 |
| 110 | MP0003635_abnormal_synaptic_transmissio | 0.28055127 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.26157723 |
| 112 | MP0004043_abnormal_pH_regulation | 0.24686585 |
| 113 | MP0002066_abnormal_motor_capabilities/c | 0.24653726 |
| 114 | MP0004811_abnormal_neuron_physiology | 0.24497335 |
| 115 | MP0005166_decreased_susceptibility_to | 0.23663915 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.23659389 |
| 117 | MP0005275_abnormal_skin_tensile | 0.22273725 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.21850846 |
| 119 | MP0004142_abnormal_muscle_tone | 0.21348069 |
| 120 | MP0005187_abnormal_penis_morphology | 0.20334427 |
| 121 | MP0008770_decreased_survivor_rate | 0.20311306 |
| 122 | MP0000762_abnormal_tongue_morphology | 0.20223648 |
| 123 | MP0001943_abnormal_respiration | 0.18930642 |
| 124 | MP0002063_abnormal_learning/memory/cond | 0.18491794 |
| 125 | MP0001502_abnormal_circadian_rhythm | 0.17927233 |
| 126 | MP0005535_abnormal_body_temperature | 0.17815811 |
| 127 | MP0001529_abnormal_vocalization | 0.17358159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 8.66017211 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 8.52109840 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.14346689 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 8.00136104 |
| 5 | Nemaline bodies (HP:0003798) | 7.54149751 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.04010783 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 6.61705184 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 6.25925532 |
| 9 | Distal arthrogryposis (HP:0005684) | 5.51870997 |
| 10 | Myopathic facies (HP:0002058) | 5.51343534 |
| 11 | Myoglobinuria (HP:0002913) | 5.35711916 |
| 12 | Muscle fiber splitting (HP:0003555) | 5.16126687 |
| 13 | EMG: myopathic abnormalities (HP:0003458) | 4.83073409 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 4.72981358 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.69796389 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 4.69110264 |
| 17 | Difficulty running (HP:0009046) | 4.66636856 |
| 18 | Round ear (HP:0100830) | 4.61734570 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.55984725 |
| 20 | Subaortic stenosis (HP:0001682) | 4.55984725 |
| 21 | Rhabdomyolysis (HP:0003201) | 4.42491465 |
| 22 | Increased connective tissue (HP:0009025) | 4.33770328 |
| 23 | Muscle stiffness (HP:0003552) | 4.30204210 |
| 24 | Myotonia (HP:0002486) | 4.21700409 |
| 25 | Sudden death (HP:0001699) | 4.17481025 |
| 26 | Calcaneovalgus deformity (HP:0001848) | 4.09922705 |
| 27 | Absent phalangeal crease (HP:0006109) | 3.85985266 |
| 28 | Deformed tarsal bones (HP:0008119) | 3.67418397 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.63090251 |
| 30 | Ventricular tachycardia (HP:0004756) | 3.41455459 |
| 31 | Areflexia of lower limbs (HP:0002522) | 3.36245018 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.33048266 |
| 33 | Neck muscle weakness (HP:0000467) | 3.30023127 |
| 34 | Abnormal finger flexion creases (HP:0006143) | 3.26583341 |
| 35 | Malignant hyperthermia (HP:0002047) | 3.26500093 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.25555669 |
| 37 | Rimmed vacuoles (HP:0003805) | 3.24520153 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 3.24414927 |
| 39 | Pelvic girdle muscle weakness (HP:0003749) | 2.95086342 |
| 40 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.82432341 |
| 41 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.82432341 |
| 42 | Shoulder girdle muscle weakness (HP:0003547) | 2.80838187 |
| 43 | Frequent falls (HP:0002359) | 2.80602147 |
| 44 | Lipoatrophy (HP:0100578) | 2.76682836 |
| 45 | Abnormality of the neuromuscular junction (HP:0003398) | 2.70719663 |
| 46 | Fatigable weakness (HP:0003473) | 2.70719663 |
| 47 | Bundle branch block (HP:0011710) | 2.69812531 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.68321013 |
| 49 | Atrial fibrillation (HP:0005110) | 2.62209054 |
| 50 | Primary atrial arrhythmia (HP:0001692) | 2.51594296 |
| 51 | Hyperkalemia (HP:0002153) | 2.47215472 |
| 52 | Dilated cardiomyopathy (HP:0001644) | 2.46502355 |
| 53 | Muscular dystrophy (HP:0003560) | 2.45691093 |
| 54 | Bulbar palsy (HP:0001283) | 2.44320619 |
| 55 | Supraventricular tachycardia (HP:0004755) | 2.43345200 |
| 56 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.39036079 |
| 57 | Abnormality of the calcaneus (HP:0008364) | 2.38058280 |
| 58 | Limb-girdle muscle atrophy (HP:0003797) | 2.35718627 |
| 59 | Supraventricular arrhythmia (HP:0005115) | 2.34440689 |
| 60 | Palpitations (HP:0001962) | 2.28970427 |
| 61 | Abnormality of the foot musculature (HP:0001436) | 2.27585295 |
| 62 | Generalized muscle weakness (HP:0003324) | 2.26842097 |
| 63 | Slender build (HP:0001533) | 2.25033749 |
| 64 | Weak cry (HP:0001612) | 2.24971261 |
| 65 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.24714555 |
| 66 | Heart block (HP:0012722) | 2.20882295 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.19549226 |
| 68 | Limb-girdle muscle weakness (HP:0003325) | 2.17802952 |
| 69 | Proximal amyotrophy (HP:0007126) | 2.15235326 |
| 70 | Foot dorsiflexor weakness (HP:0009027) | 2.12964788 |
| 71 | Abnormal atrioventricular conduction (HP:0005150) | 2.11068796 |
| 72 | Prolonged QT interval (HP:0001657) | 2.11025368 |
| 73 | Paralysis (HP:0003470) | 2.10545190 |
| 74 | Facial diplegia (HP:0001349) | 2.08446447 |
| 75 | Gowers sign (HP:0003391) | 2.08038317 |
| 76 | Ragged-red muscle fibers (HP:0003200) | 2.05210218 |
| 77 | EMG: neuropathic changes (HP:0003445) | 2.02819048 |
| 78 | Hypoplastic ischia (HP:0003175) | 2.00101165 |
| 79 | Progressive muscle weakness (HP:0003323) | 1.97173407 |
| 80 | Nonprogressive disorder (HP:0003680) | 1.95601044 |
| 81 | Fetal akinesia sequence (HP:0001989) | 1.94734162 |
| 82 | Spinal rigidity (HP:0003306) | 1.94289427 |
| 83 | Hip contracture (HP:0003273) | 1.93191467 |
| 84 | Ventricular arrhythmia (HP:0004308) | 1.88328267 |
| 85 | Right ventricular cardiomyopathy (HP:0011663) | 1.84317045 |
| 86 | Lower limb amyotrophy (HP:0007210) | 1.82059087 |
| 87 | Left ventricular hypertrophy (HP:0001712) | 1.81181307 |
| 88 | Cholelithiasis (HP:0001081) | 1.80495631 |
| 89 | Scapular winging (HP:0003691) | 1.77427591 |
| 90 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.77363411 |
| 91 | Exercise intolerance (HP:0003546) | 1.76964006 |
| 92 | Metatarsus adductus (HP:0001840) | 1.74362310 |
| 93 | Abnormal EKG (HP:0003115) | 1.74177037 |
| 94 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.73582627 |
| 95 | Toxemia of pregnancy (HP:0100603) | 1.70477740 |
| 96 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.68715387 |
| 97 | Abnormality of the ischium (HP:0003174) | 1.67770883 |
| 98 | Hyperalaninemia (HP:0003348) | 1.65502251 |
| 99 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65502251 |
| 100 | Abnormality of alanine metabolism (HP:0010916) | 1.65502251 |
| 101 | Achilles tendon contracture (HP:0001771) | 1.64862419 |
| 102 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.60565365 |
| 103 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.60330928 |
| 104 | Type 2 muscle fiber atrophy (HP:0003554) | 1.60314204 |
| 105 | Short palpebral fissure (HP:0012745) | 1.59964586 |
| 106 | Waddling gait (HP:0002515) | 1.59670568 |
| 107 | Atrioventricular block (HP:0001678) | 1.58198318 |
| 108 | Increased intramyocellular lipid droplets (HP:0012240) | 1.57780103 |
| 109 | Abnormality of the Achilles tendon (HP:0005109) | 1.57573395 |
| 110 | Adducted thumb (HP:0001181) | 1.53587274 |
| 111 | Abnormality of glycolysis (HP:0004366) | 1.52076524 |
| 112 | Ulnar deviation of finger (HP:0009465) | 1.49920303 |
| 113 | Increased serum pyruvate (HP:0003542) | 1.48783700 |
| 114 | Increased muscle lipid content (HP:0009058) | 1.45239969 |
| 115 | Limited hip movement (HP:0008800) | 1.41519215 |
| 116 | Popliteal pterygium (HP:0009756) | 1.36093408 |
| 117 | Muscle fiber atrophy (HP:0100295) | 1.35862330 |
| 118 | Congenital hip dislocation (HP:0001374) | 1.34971659 |
| 119 | Oligomenorrhea (HP:0000876) | 1.33015131 |
| 120 | Gout (HP:0001997) | 1.31039764 |
| 121 | Stridor (HP:0010307) | 1.29807350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.20584854 |
| 2 | TTN | 6.09470447 |
| 3 | PHKG1 | 5.29365848 |
| 4 | PHKG2 | 5.29365848 |
| 5 | NME1 | 3.50823086 |
| 6 | PIK3CG | 2.88144623 |
| 7 | MAP2K3 | 2.77993040 |
| 8 | PINK1 | 2.60830710 |
| 9 | NEK1 | 2.44842280 |
| 10 | DMPK | 2.31469444 |
| 11 | ZAK | 2.10585548 |
| 12 | MUSK | 2.09249471 |
| 13 | TRIB3 | 1.81285932 |
| 14 | ICK | 1.71219727 |
| 15 | MAPK12 | 1.69186804 |
| 16 | MAP2K4 | 1.54459880 |
| 17 | TAOK2 | 1.54244900 |
| 18 | PIK3CA | 1.52317907 |
| 19 | MAP3K7 | 1.50703313 |
| 20 | PDK3 | 1.44536870 |
| 21 | PDK4 | 1.44536870 |
| 22 | ERBB3 | 1.43314751 |
| 23 | MAP2K6 | 1.41100483 |
| 24 | STK24 | 1.32921253 |
| 25 | LIMK1 | 1.23442188 |
| 26 | MAP3K9 | 1.10229678 |
| 27 | MAP3K5 | 1.09533508 |
| 28 | LMTK2 | 1.08104196 |
| 29 | TRPM7 | 1.07573937 |
| 30 | MAP2K7 | 1.07405600 |
| 31 | BCKDK | 1.07201041 |
| 32 | LATS2 | 1.03601180 |
| 33 | DYRK1B | 1.02968320 |
| 34 | PDK2 | 0.99346247 |
| 35 | MAPKAPK3 | 0.98724701 |
| 36 | PKN2 | 0.97911531 |
| 37 | KSR2 | 0.87589015 |
| 38 | SIK1 | 0.87303415 |
| 39 | PRKAA1 | 0.85995528 |
| 40 | ARAF | 0.83699549 |
| 41 | MARK1 | 0.80575355 |
| 42 | MOS | 0.80189943 |
| 43 | TNIK | 0.75098976 |
| 44 | CCNB1 | 0.73891342 |
| 45 | MYLK | 0.72405111 |
| 46 | MAP3K4 | 0.71917680 |
| 47 | PAK6 | 0.66081095 |
| 48 | RPS6KA2 | 0.66048892 |
| 49 | MAP3K3 | 0.64213678 |
| 50 | CAMK2B | 0.61275043 |
| 51 | SGK3 | 0.61201010 |
| 52 | CAMK1 | 0.61127020 |
| 53 | TAOK1 | 0.58933537 |
| 54 | TBK1 | 0.54966436 |
| 55 | CDK19 | 0.54597299 |
| 56 | MAP3K11 | 0.54017763 |
| 57 | ILK | 0.52762281 |
| 58 | FGFR4 | 0.52634274 |
| 59 | NTRK1 | 0.51695691 |
| 60 | INSRR | 0.50844665 |
| 61 | MARK2 | 0.50553507 |
| 62 | AKT2 | 0.48627210 |
| 63 | EEF2K | 0.46973942 |
| 64 | SGK2 | 0.45530003 |
| 65 | MAPK13 | 0.45315252 |
| 66 | UHMK1 | 0.44290490 |
| 67 | BRAF | 0.43456756 |
| 68 | NME2 | 0.43367810 |
| 69 | MTOR | 0.42181655 |
| 70 | MAP3K13 | 0.41672231 |
| 71 | ROCK1 | 0.40924569 |
| 72 | MAPK7 | 0.40829369 |
| 73 | NEK9 | 0.40623904 |
| 74 | RIPK1 | 0.39422459 |
| 75 | EPHA4 | 0.39336760 |
| 76 | CAMKK1 | 0.39059580 |
| 77 | PRKAA2 | 0.38313735 |
| 78 | RPS6KC1 | 0.37990225 |
| 79 | RPS6KL1 | 0.37990225 |
| 80 | CDK8 | 0.37210206 |
| 81 | MAPK10 | 0.37187218 |
| 82 | CAMK2G | 0.36892336 |
| 83 | MAPK11 | 0.36668497 |
| 84 | PRKD1 | 0.36457295 |
| 85 | EPHB2 | 0.35484651 |
| 86 | SGK223 | 0.33212874 |
| 87 | SGK494 | 0.33212874 |
| 88 | KSR1 | 0.32928464 |
| 89 | PRPF4B | 0.32770283 |
| 90 | RPS6KA6 | 0.32472211 |
| 91 | NTRK2 | 0.32269176 |
| 92 | FLT3 | 0.31455861 |
| 93 | CAMK4 | 0.31061719 |
| 94 | MAP3K6 | 0.30990867 |
| 95 | PKN1 | 0.30915554 |
| 96 | MAP3K1 | 0.30847134 |
| 97 | PRKD3 | 0.30357344 |
| 98 | CDK11A | 0.28545535 |
| 99 | PRKG1 | 0.28195598 |
| 100 | DAPK2 | 0.27982834 |
| 101 | CAMK2D | 0.27603123 |
| 102 | PDPK1 | 0.27507090 |
| 103 | PRKACB | 0.27461391 |
| 104 | CDK15 | 0.27225289 |
| 105 | CDK5 | 0.26859103 |
| 106 | RPS6KB2 | 0.26642497 |
| 107 | SGK1 | 0.26357927 |
| 108 | TNK2 | 0.25724649 |
| 109 | EPHA2 | 0.25499518 |
| 110 | PRKCH | 0.24850554 |
| 111 | PDGFRA | 0.24640710 |
| 112 | SMG1 | 0.24571009 |
| 113 | RPS6KB1 | 0.24229592 |
| 114 | RPS6KA1 | 0.23523102 |
| 115 | NTRK3 | 0.22989508 |
| 116 | CDK18 | 0.22736191 |
| 117 | MAP3K10 | 0.22716748 |
| 118 | PDK1 | 0.22345746 |
| 119 | TYRO3 | 0.21816036 |
| 120 | SIK3 | 0.21138226 |
| 121 | EPHB1 | 0.21132715 |
| 122 | TESK1 | 0.20441973 |
| 123 | RPS6KA3 | 0.20423297 |
| 124 | IRAK3 | 0.20420332 |
| 125 | TIE1 | 0.20133828 |
| 126 | PRKACA | 0.19255435 |
| 127 | CDK14 | 0.19008387 |
| 128 | BRSK1 | 0.18358564 |
| 129 | PTK2 | 0.17415950 |
| 130 | SIK2 | 0.16526552 |
| 131 | MAPK4 | 0.15847536 |
| 132 | IKBKE | 0.14339991 |
| 133 | MAPK8 | 0.13523424 |
| 134 | TYK2 | 0.12143986 |
| 135 | EIF2AK1 | 0.12044362 |
| 136 | MINK1 | 0.10720963 |
| 137 | PLK2 | 0.10227547 |
| 138 | CAMK2A | 0.10213360 |
| 139 | MAP2K1 | 0.10133944 |
| 140 | SYK | 0.10031009 |
| 141 | STK38L | 0.09939049 |
| 142 | CDK3 | 0.09702124 |
| 143 | PIM2 | 0.08357567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.07799932 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.36008031 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.06514641 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.84325443 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.40134558 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.38987268 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.39118787 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26535725 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.21697429 |
| 10 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.20359777 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.07524466 |
| 12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.01690537 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 1.99616457 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.98606061 |
| 15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.93345665 |
| 16 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.87962045 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.87321443 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.80339846 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.75763991 |
| 20 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.74315212 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65501577 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63508193 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58793955 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.54411250 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.46567527 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41684294 |
| 27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.39039928 |
| 28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.35730262 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.29013867 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26362916 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26078672 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23072931 |
| 33 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.19476368 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14591912 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11208407 |
| 36 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10937823 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02531281 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92791487 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92073713 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91789661 |
| 41 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86444354 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86331337 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 0.85357799 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84452888 |
| 45 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83061667 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81948372 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80431474 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79864183 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79206844 |
| 50 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77855240 |
| 51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76176069 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75739221 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75527357 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75417342 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75003749 |
| 56 | Proteasome_Homo sapiens_hsa03050 | 0.74356759 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68731138 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67570663 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.67198850 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66460814 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66364435 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.62898351 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62306805 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61619384 |
| 65 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.60176421 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.58490346 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57792981 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56990989 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55655182 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55454897 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55339006 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55175578 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55076984 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54318184 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53933273 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53669097 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53154863 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.52962560 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52695321 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51678798 |
| 81 | DNA replication_Homo sapiens_hsa03030 | 0.47192568 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.44915855 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.44575300 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.44088326 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43922211 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43896670 |
| 87 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43272845 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42673645 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.41936527 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41681984 |
| 91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41616612 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40401281 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39975995 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.38282057 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38059452 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37620790 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37469751 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36938347 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.35137043 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34887650 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34722129 |
| 102 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34413351 |
| 103 | GABAergic synapse_Homo sapiens_hsa04727 | 0.34381001 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.33869864 |
| 105 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.33833492 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33437400 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32739869 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.31981447 |
| 109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.31528847 |
| 110 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.30177512 |
| 111 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30079517 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.29989632 |
| 113 | Axon guidance_Homo sapiens_hsa04360 | 0.29926591 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29314962 |
| 115 | Base excision repair_Homo sapiens_hsa03410 | 0.28544755 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.28365714 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.28289780 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27679561 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26702825 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.25878067 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25661124 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25258053 |
| 123 | Gap junction_Homo sapiens_hsa04540 | 0.24964421 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.24729343 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24539602 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24311991 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22497267 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.22422967 |
| 129 | Salivary secretion_Homo sapiens_hsa04970 | 0.21586771 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.21382327 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21341182 |
| 132 | Legionellosis_Homo sapiens_hsa05134 | 0.21337795 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.20864246 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.19546127 |
| 135 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.19197476 |
| 136 | Hepatitis B_Homo sapiens_hsa05161 | 0.18709397 |
| 137 | Morphine addiction_Homo sapiens_hsa05032 | 0.18610214 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.16938701 |

